Weight Loss Treatments Near Des Moines
What is Tirzepatide?
The Coachlight Clinic is excited to announce our partnership with Des Moines Plastic Surgery, our esteemed neighbor in West Des Moines.
Together, we are thrilled to offer cutting-edge tirzepatide treatments to our valued guests. These treatments are designed to effectively address long-term weight loss goals and management. Tirzepatide involves a weekly injection that has been proven to reduce appetite.
When combined with a wholesome diet and a healthy lifestyle, tirzepatide has shown great potential in promoting sustainable weight loss. We are proud to provide tirzepatide treatments at both our Ankeny and West Des Moines locations.
Tirzepatide is a once-weekly injectable peptide medication and is the key element in FDA-approved brands Mounjaro for treating diabetes and Zepbound for combating obesity and excess weight.
How Does Tirzepatide Work?
Tirzepatide acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both the GIP and GLP-1 receptors, it effectively regulates glucose levels and promotes weight loss.
benefits of a Tirzepatide Treatment
Tirzepatide, acting as a GIP receptor and GLP-1 receptor agonist, yields noteworthy enhancements in glycemic control and substantial weight reduction in individuals with type 2 diabetes.
Additionally, it demonstrates efficacy in the improvement of hemoglobin A1C levels and is utilized off-label for the treatment of obesity.
Tirzepatide Treatment vs. Semiglutide Treatment
In prescription medication, semaglutide is utilized at higher dosages and marketed as Wegovy for weight loss purposes, while at lower dosages, it is marketed as Ozempic for the treatment of diabetes. Similarly, tirzepatide is marketed as Mounjaro for FDA-approved diabetes treatment, while Zepbound is the brand name for its marketing as an obesity and weight management solution.
Both tirzepatide and semaglutide are medications currently under investigation and development for treating type 2 diabetes and obesity. Belonging to the glucagon-like peptide-1 (GLP-1) receptor agonist class of drugs, they share certain similarities but also exhibit notable differences.
Tirzepatide functions as a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist. By activating both the GIP and GLP-1 receptors, it effectively regulates glucose levels and promotes weight loss. In contrast, semaglutide is a selective GLP-1 receptor agonist that primarily targets and activates the GLP-1 receptor. This mechanism improves glycemic control and has the potential for weight loss.
Clinical trials have shown that both tirzepatide and semaglutide have significant potential for weight loss. However, tirzepatide has exhibited a more pronounced effect on weight reduction compared to semaglutide. Studies suggest that tirzepatide may have a greater impact on reducing weight in individuals with obesity or overweight, surpassing the effects of semaglutide.
Determine If You’re a Tirzepatide Candidate by Scheduling a FREE Phone Consult at Des Moines Plastic Surgery
Before, During, and After
What To Expect Before A Tirzepatide Treatment
Guests interested in tirzepatide injectable treatments in the greater Des Moines area should complete an initial complimentary phone consultation to determine suitability as a candidate for the treatment.
During the consultation, we will review your medical history and discuss the treatment, expectations, and potential side effects in detail. If deemed a suitable candidate, an appointment for the first dose can be scheduled.
What To Expect During A Tirzepatide Treatment
During the initial appointment and administration, you will undergo weight measurement, body measurements, lifestyle practices review, and a discussion of expectations while receiving tirzepatide treatments. The first dose will be administered. Our tirzepatide program consists of a series of eight once-a-week treatments.
The convenience lies in the fact that after the first dose, the subsequent seven doses can be taken home and self-administered weekly. Upon completing the final (eighth) dose, patients will return for a follow-up appointment at our facility to evaluate weight loss outcomes and determine the subsequent course of action, including the continuation of additional treatments. We will also assess and make appropriate dosage adjustments as necessary.
What To Expect After A Tirzepatide Treatment
Upon completing the initial 8-week treatment phase, we will evaluate your progress and long-term weight loss goals. If you aim to maintain your current weight, we will recommend continuing treatments at a maintenance dosage. The ultimate goal will be to gradually reduce the dose until you no longer require or desire weekly treatments. Alternatively, if you wish to achieve further weight loss, we will create a continued weekly dosage plan and make appropriate recommendations.
It’s important to note that clinical studies with tirzepatide and semaglutide have shown weight loss in subjects who received the medication for an average period of 3 to 6 months. Establishing lasting, healthy lifestyle habits and behaviors through dietary adjustments and physical activity is crucial for sustainable long-term weight loss. Your commitment to these changes will contribute to maintaining the weight loss achieved while using tirzepatide treatments.
Frequently Asked Questions
Related Treatments
What People Are Saying
Coachlight is known as a destination of beauty and wellness and Iowa’s top medical aesthetic provider, serving guests with Des Moines Plastic Surgery for over 15 years.
